Generic placeholder image

Current Protein & Peptide Science

Editor-in-Chief

ISSN (Print): 1389-2037
ISSN (Online): 1875-5550

Recombinant Antibodies in Cancer Therapy

Author(s): M. S. Nayeem and Rizwan H. Khan

Volume 7, Issue 2, 2006

Page: [165 - 170] Pages: 6

DOI: 10.2174/138920306776359768

Price: $65

Abstract

The application of recombinant immunotoxin and radioimmunoconjugate in Cancer therapy has revived the "magic bullet" concept predicted a century ago. Many of the recombinant antibodies have received FDA approval for various indication of cancer in recent years and numerous others are in clinical trials.

Keywords: Cancer therapy, recombinant immunotoxins, radioimmunoconjugates, engineered antibody, recombinant antibody


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy